SHP-ELA-401: A Long-Term, Open-Label, Multicenter, Phase IV Study to Assess Longitudinal Changes on Height and Weight in Patients with MPS II Who Are Receiving Elaprase and Started Treatment With Elaprase at <6 Years of Age

Project: Research project

Project Details

StatusFinished
Effective start/end date4/13/15 → 6/4/21

Funding

  • Shire Human Genetic Therapies, Inc.